SCHEMBL3242409

SCHEMBL3242409

[CH2]c1ccc(CN(C)Cc2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
TSHR P16473 2/20 0.54
CARM1 Q86X55 1/20 0.53
PRMT6 Q96LA8 1/20 0.53
PRMT8 Q9NR22 1/20 0.53
KDM4E B2RXH2 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
LMNA P02545 2/20 0.52
USP2 O75604 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
PYCR1 P32322 1/20 0.52
BLM P54132 1/20 0.50
AOC3 Q16853 1/20 0.50
ACHE P22303 3/20 0.49
BCHE P06276 1/20 0.49
SIGMAR1 Q99720 1/20 0.48
HRH3 Q9Y5N1 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dibemethine SCHEMBL10542007 0.86 ALDH1A1 (0.70) ALDH1A1TSHRCARM1PRMT6PRMT8
Dibemethine SCHEMBL276863 0.86 ALDH1A1 (0.70) ALDH1A1TSHRCARM1PRMT6PRMT8
Dibemethine SCHEMBL2139708 0.84 ALDH1A1 (0.67) ALDH1A1TSHRCARM1PRMT6PRMT8
SCHEMBL3240490 0.82 CNR2 (0.53) ALDH1A1TSHRKDM4EAOC3HRH3
SCHEMBL3240150 0.81 PYCR1 (0.56) ALDH1A1KDM4ESMN1; SMN2LMNAPYCR1
SCHEMBL10194246 0.80 CYP2C19 (0.61) ALDH1A1TSHRCARM1PRMT6PRMT8
SCHEMBL8251052 0.80 TP53 (0.64) ALDH1A1TSHRCARM1PRMT6PRMT8
SCHEMBL3239914 0.80 CHRNB2 (0.67) ALDH1A1KDM4ELMNAGAA
SCHEMBL22305213 0.79 KDM4E (0.61) ALDH1A1TSHRCARM1PRMT6PRMT8
SCHEMBL3235188 0.79 CNR2 (0.56) ALDH1A1TSHRKDM4EMAOBACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144733-A1 Compounds, compositions and methods comprising heteroaromatic derivatives INSTITUTE FOR ONEWORLD HEALTH 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144733-A1 Compounds, compositions and methods comprising heteroaromatic derivatives CFTR, PKD1, PKD2 ALDH1A1 2115/4885TSHR 2802/4885CARM1 4323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.